{"id":"W4409986064","doi":"10.1001/jamadermatol.2025.0982","title":"Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents","year":2025,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre; XLV Diagnostics (Canada); SKiN Health","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Randomized controlled trial; Adverse effect; Internal medicine; Clinical trial; Severity of illness; Pediatrics; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008261518,0.0002812084,0.0008258267,0.0001246221,0.000209501,0.0002832132,0.0002360588,0.0004088327,0.001988162],"category_scores_gemma":[0.0006124781,0.0001177475,0.0005873233,0.0001472752,0.0002012953,0.0002030363,0.0001105041,0.0005525476,0.0001848047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003216128,"about_ca_system_score_gemma":0.0006854394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008515364,"about_ca_topic_score_gemma":0.003856625,"domain_scores_codex":[0.9996613,0.0001726008,0.00003967385,0.00004177896,0.00004653682,0.00003800261],"domain_scores_gemma":[0.9995332,0.0001099134,0.0001700996,0.00001028005,0.00003115773,0.0001454265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3383323,0.009129495,0.2576792,0.005128457,0.003730011,0.0007442179,0.0002830127,0.0011866,0.02744777,0.0004716615,0.01089323,0.3449741],"study_design_scores_gemma":[0.3088022,0.1912541,0.4641734,0.001150536,0.003978686,0.002814916,0.000324224,0.001986445,0.007661621,0.000341196,0.01747402,0.00003873607],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978851,0.0184608,0.0001608783,0.0003918395,0.0001083798,0.000324399,0.0003187103,0.00001874979,0.001365285],"genre_scores_gemma":[0.9954477,0.002743153,0.0003333446,0.0004185431,0.0001327077,0.0002295317,0.0002280559,0.000001814464,0.0004651474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001988162,"threshold_uncertainty_score":0.006651103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00868481131928063,"score_gpt":0.2800234437918701,"score_spread":0.2713386324725894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}